L-ergothioneine, milk thistle, and S-adenosylmethionine for...

Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S046000, C514S398000, C514S399000

Reexamination Certificate

active

06863906

ABSTRACT:
This invention provides therapeutic compositions and combinations for the protection, treatment and repair of liver tissue. The invention relates to novel compositions and combinations comprising two or more compounds selected from the group consisting of S-adenosylmethionine, L-ergothioneine, and a substance selected from the group consisting of constituents of Milk thistle (Silybum marianum), silymarin and active components of silymarin, whether naturally, synthetically, or semi-synthetically derived, and to methods of preventing and treating liver disease and of repairing damaged liver tissue. The invention also provides a method of administering these compositions and combinations to humans or animals in need thereof.

REFERENCES:
patent: 3882228 (1975-05-01), Boncey et al.
patent: 3887700 (1975-06-01), Boncey et al.
patent: 4061765 (1977-12-01), Madaus et al.
patent: 4100160 (1978-07-01), Walser
patent: 4296127 (1981-10-01), Walser
patent: 4314989 (1982-02-01), Rosen
patent: 4994457 (1991-02-01), Crawford et al.
patent: 5084482 (1992-01-01), Hirsch et al.
patent: 5137712 (1992-08-01), Kask et al.
patent: 5288503 (1994-02-01), Wood et al.
patent: 5474757 (1995-12-01), Yang
patent: 5569458 (1996-10-01), Greenberg
patent: 6255295 (2001-07-01), Henderson et al.
patent: 6271213 (2001-08-01), Henderson et al.
patent: 6555141 (2003-04-01), Corson et al.
patent: 6583123 (2003-06-01), Henderson et al.
Adachi et al., “The Effects of S-adenosylmethionine on Intrahepatic Cholestatis,” Jpn. Arch. Int. Med., 33(6): 185-192 (1986).
Akanmu, D. et al., “The Antioxidant Action of Ergothioneine,” Archives of Biochemistry and Biophyiscs, 288(1): 10-16 (1991).
Alvaro, D. et al., S-adenosylmethionine (SAMe) protects against acute ethanol hepatotoxicity in the isolated perfused rat liver (IPRL) with no effect on trascytosis, EASL, Journal of Hepatology, 21(Suppl. 1): S81 (1994).
Arias, I.M. and Kinne, R., On the pathophysiology and reversibility of intrahepatic cholestasis, Clinical Research, 32:548A (1984).
Aruoma O.I. et al., “Antioxidant action of ergothioneine: assessment of its ability to scavenge peroxynitrite,” Biochem. Biophys. Res. Commun. 231(2): 389-91, abstract (Feb. 13, 1997).
Baldessarini, R., “Neuropharmacology of S-Adenyosyl-L-Methionine,” American Journal of Medicine, 83(5A): 95-103 (1987).
Barrio, E. et al., Comparative effect of nifedipine and s-adenosylmethionine, singly and in combination on experimental rat liver cirrhosis, Life Sciences, 52:PL 217-220 (1993).
Belli, D.C. et al., S-adenosylmethionine prevents total parenteral nutrition-induced cholestasis in the rat, Journal of Hepatology, 21: 18-23 (1994).
Bortolini, M. et al., Multicentre Survey of the Prevalence of Intrahepatic Cholestasis in 2520 Consecutive Patients with Newly Diagnosed Chronic Liver Disease, Drug Investigation, 4(Suppl. 4): 83-89 (1992).
Botero, R.C., Placebo controlled trial of intravenous S-Adenosylmethionine (SAMe) in patients with acute hepatitis A, B, and NANB, Hepatology, 14(4):199A (1991).
Bray, G.P. et al., A comparison of S-Adenosylmethionine (SAMe), rifampicin (R) and ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC): interim results, Journal of Hepatology, 13(Suppl. 2):S101 (1991).
Bray, G.P. et al., Resolution for danazol-induced cholestasis with S-Adenosylmethionine, Postgrad. Med. J., 69:237-239 (1993).
Bray, G.P., et al., S-Adenosylmethionine Protects against Acetaminophen Hepatotoxicity in Two Mouse Models, Hepatology, 15(2): 297-301 (1992).
Brown, M.D. et al., s-Adenosyl-L-methionine modulates Na++ K+-ATPase activity in rat colonic basolateral membranes, Biochem. J., 251:215-222 (1988).
Brummel, M.C., “In Search of a Physiological Function for L-ergothioneine,-II,” Med. Hypotheses, 30(1):39-48 (Sep. 1989).
Buchet, J-P. et al., The influence of liver disease on the methylation of arsenile in humans. Archives of Toxicology, 55: 151-154 (1984).
Caballeria, E. and Moreno, J., Therapeutic effects of S-Adenosylmethionine (SAMe) in hepatic steatosis, A pilot study, Acta Therapeutica, 16: 253-264 (1990).
Caballeria, J. et al., Effects of S-adenosylmethionine (SAMe) on experimental liver fibrosis. In: Falk symposium 71. Fat-storing Cells and Liver Fibrosis, Surrenti, C. et al. (Eds.) Kluwer Academic Publishers, Lancaster, UK, 314-321 (1994).
Cacciatore, L. et al., S-Adenosylmethionine (SAMe) in the treatment of pruritus in chronic liver disease, Acta Therapeutica, 15: 363-371 (1989).
Carney, M., Neuropharmacology of S-Adenosyl Methionine, Clinical Neuropharmacology, 9(3): 235-243 (1986).
Casini, A. et al., S-Adenosylmethionine Inhibits Collagen Synthesis by Human Fibroblast In Vitro, Meth. and Find. Exp. Clin. Pharmacol., 11(5):331-334 (1989).
Champe, P., Biochemistry, 2nd Edition, J.B. Lippincott Co., Philadelphia, 1994, pp. 248, 250 and 265.
Chawla, R.K. et al., Effect of Ethanol Consumption on Metabolism of S-Adenosyl-L-Methionine in Rat Liver, Drug Investigation, 4 (Suppl. 4): 41-45 (1992).
Chawla, R.K. and Jones, D.P., “Abnormal metabolism of S-adenosyl-L-methionine in hypoxic rat liver. Similarities to its abnormal metabolism in alcholic cirrhosis,” Biochimia et Biophysica Acta, 1199: 45-51 (1994).
Cibin, M. et al., S-Adenosylmethionine (SAMe) is effective in reducing ethanol abuse in an outpatient program for alcoholics, Biochmeical and social aspects of alcohol and alcoholism, Kuriyama, K. et al. (eds.) Elsevier Science Publishers B.V. (Biomedical Division), 357-360 (1988).
Concari, M. et al., S-adenosyl-L-methionine (SAMe) reduces hepatotoxicity induced by hydrophobic bile salts (BS) in hepG2 cell line, EASL, Journal of Hepatology, 21(Suppl. 1):S77 (1994).
Conti, M. et al., Protective Activity of Silipide on Liver Damage in Rodents, Japan J. Pharmacol., 60:315-21 (1992).
Corrales, F. et al., S-adenosylmethionine Treatment Prevents Carbon Tetracholoride-induced S-adenosylmethionine Synthetase Inactivation and Attenuates Liver Injury, Hepatology, 16(4):1022-1027 (1992).
Cuomo, R. et al., Bile and biliary lipid secretion in rats with hexachlorobenzene-induced prophyria. Effect of S-adenosyl-L-methionine administration, Journal of Hepatology, 12: 87-93 (1991).
Cuomo, R. et al., Nicotinamide methylation in patients with cirrhosis, Journal of Hepatology, 20: 138-142 (1994).
Cuomo, R. et al., S-Adenosyl-L-Methionine (SAMe)-dependent nicotinamide methylation: a marker of hepatic damage, In: Falk Symposium 71-Fat Storing Cells and Liver Fibrosis, Surrenti, C. et al. (Eds.), Kluwer Academic Publishers, Lancaster, UK, 348-353 (1994).
Cutrin, C. et al., Effect of nifedipine and S-Adenosylmethionine in the liver of rats treated with CC14and ethanol for one month, Life Sciences, 51:PL 113-118 (1992).
Cutrin, C. et al., Lactacidaemia in rats with cirrhosis induced by carbon tetrachloride and ethanol: treatment with colchicine, nifedipine and S-adenosylmethionine, Med. Sci. Res., 19:351-352 (1991).
Dausch et al., “Increased Levels of S-Adenosylmethionine in the Livers of Rats Fed Various Forms of Selenium,” Nutrition and Cancer, 20 (1) 31-39-(1993).
Devi, B.G. et al., Effect of Ethanol on Rat Fetal Hepatocytes: Studies on Cell Replication, Lipid Peroxidation and Glutathione, Hepatology, 18(3):648-659 (1993).
Devi, B. et al., Protection of rat fetal hepatocytes membranes from ethanol mediated cell injury and growth impairment, Hepatology, 16: 109A (1992).
Di Padova, C. et al., Decreased Blood Levels of Ethanol and Acetaldehyde by S-Adenosyl-L-Methionine in Humans, Disease, Metabolism, and Reproduction in the Toxic Response to Drugs and Other Chemicals, Arch. of Toxicol., Suppl. 7: 240-242 (1984).
Di Padova, D. et al., S-Adenosyl-L-Methionine protection against α-naphthyl-isothlocyanate-induced cholestasis in the rat, Toxicology Letters, 29:131-136 (1985).
Dunne, B. et al., S-adenosylmethionine improves hepatic function during liver perfusion after sequential cold and warm ischaemic injury. Submitted to: British Transplant Society (1992).
Dunne, B. et al., Benefit of S-adenosylmethionin

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

L-ergothioneine, milk thistle, and S-adenosylmethionine for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with L-ergothioneine, milk thistle, and S-adenosylmethionine for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and L-ergothioneine, milk thistle, and S-adenosylmethionine for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3383586

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.